0:00 Intro
0:38 VC Dirty Money (LP Sources)
8:30 Power Dynamics Founder vs VC
12:56 Trillion $ Alzheimer's Opportunity
14:26 Eli Lily's New Alzheimer's Blockbuster (?) Donanemab
19:01 More Issues with Donanemab Phase III Results
21:48 Will Anyone Pay for Donanemab?
24:13 Donanemab Side Effects
27:15 Startup Opportunities in Alzheimer's
31:34 Outro
Articles Mentioned
Founders need to take a stand against VC's 'dirty money’: https://sifted.eu/articles/founders-vc-dirty-money
Eli Lily Donanemab Phase III Press Release: https://investor.lilly.com/news-releases/news-release-details/lillys-donanemab-significantly-slowed-cognitive-and-functional
Cost Effectiveness of Donanemab: https://pubmed.ncbi.nlm.nih.gov/35344024/
Podcast Links
YouTube: https://www.youtube.com/@bigpicturemedicine
Apple: https://podcasts.apple.com/gb/podcast/big-picture-medicine/id1500446262
Spotify: https://open.spotify.com/show/5707RPmWOJkVZyUHNRSUfS?si=96c7fff6bccb456a
People
Dr Imran Mahmud: https://www.imranmahmud.com/
Dr Adam Bataineh: https://twitter.com/DrAdamBat?s=20
Dr Mustafa Sultan: https://www.musty.io/
